说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 促血管生成素
1)  angiopoietin
促血管生成素
1.
Effect of method of supplementing Qi and activating blood circulation (益气活血法) on expression of angiopoietin-1 and its receptors Tie-2 in brains of rats with intracerebral hemorrhage;
益气活血法对脑出血大鼠脑组织促血管生成素-1及其受体表达的影响
2.
Relationship Between Angiopoietin and Angiogenesis of Gastric Carcinoma;
促血管生成素与胃癌血管生成的关系
3.
Chemotaxis on Umbilical Vein Endothelial Cells of SMMC7721 Hepatic Carcinoma Cells with Angiopoietin Gene Expression;
携带促血管生成素基因的肝癌细胞对血管内皮细胞的趋化作用
2)  Angiopoietin-1
促血管生成素
1.
Combination of Angiopoietin-1 and Vascular Endothelial Growth Factor at Proper Ratio Promoted Functional Neovascularization in Rats with Experimental Limb Ischemia;
促血管生成素1和血管内皮生长因子基因合适剂量配比有效促进血管生成
2.
Dynamic changes of angiopoietin-1 and the receptor Tie-2 expression in rat brains following intracerebral hemorrhage;
目的:观察与微血管系统重建过程密切相关的促血管生成素(Angiopoietin-1,Ang-1)及其受体含免疫球蛋白样环和上皮生长因子样域酪氨酸激酶-2(tyrosine kinase that contains immunoglobulin-like loops and epidermal growth factor-similar domains-2,Tie-2)在大鼠基底核脑出血后表达的动态变化。
3)  Angiopoietin-2
促血管生成素
1.
Construction and Identificatian of Human Angiopoietin-2 Antisense Eukaryotic Expression Trager;
促血管生成素-2反义真核表达载体的构建及鉴定
2.
Expressing of Angiopoietin-2 and VEGF in Transitional Cell Carcinomar of Bladder and Their Relation to Tumor Angiogenesis and Clinical Significance;
促血管生成素-2(Ang-2)及血管内皮生长因子(VEGF)在膀胱移行细胞癌中的表达与肿瘤血管生成的关系及临床意义
4)  angiopoietins
促血管生成素
1.
The regulating roles of angiopoietins/TEK-2 in angiogenesis;
促血管生成素及其受体TEK在血管形成中的调节作用
5)  angiopoietin-1
促血管生成素-1
1.
Angiopoietin-1 promotes adhesion and metastasis of human gastric cancer cell line
促血管生成素-1对人胃癌细胞黏附和转移作用的研究
2.
ObjectiveTo investigate the mechanisms of Buyang Huanwu Decoction (BYHWD) by observing its effects on expressions of angiopoietin-1 (Ang-1) and the endothelial-specific receptor tyrosine kinase (Tie-2) mRNA in damaged region of rats' brain after intracerebral hemorrhage (ICH).
目的通过观察补阳还五汤对脑出血大鼠脑内损伤区促血管生成素-1(angiopoietin-1,Ang-1)及其内皮特异性受体(endothelial-specific receptor tyrosine kinase,Tie-2)mRNA表达的影响,探讨补阳还五汤的作用机制。
3.
The Expression and Significance of the Angiopoietin-1 in the Kidney of Diabetic Rats;
目的探讨促血管生成素-1(ang iopo ietin-1,A ng-1)在糖尿病鼠肾脏中的表达变化及其意义。
6)  Ang-1
促血管生成素-1
1.
Objective To investigate the pathological mechanism of hemangioma and vascular malformation,the expression of Ang-1、Ang-2 and Tie2 in hemangioma and vascular malformation was evaluated and its significance was analyzed.
目的探讨促血管生成素-1(Ang-1)、促血管生成素-2(Ang-2)及其受体Tie2在血管瘤和血管畸形组织中的表达及意义。
2.
Objective To examine the expression level of Fas, Ang-1, Ang-2, E-cad in human ovarian epithelial tumors and explore their relationship with tumorigenesis and prognosis.
目的检测Fas、促血管生成素-1(Ang-1)、促血管生成素-2(Ang-2)、E-钙粘蛋白(E-cad)在卵巢上皮肿瘤组织中的表达水平,藉此评价其与肿瘤发生发展及预后的关系。
补充资料:舒血管素 ,血管舒缓素
药物名称:血管舒缓素

英文名:Kallidinogenase

别名: 保妥丁;激太积放酶;舒血管素 ,血管舒缓素
外文名:Kallidinogenase
适应症:
用于脑动脉硬化症、闭塞性动脉内膜炎、闭塞性血管炎、四肢慢性溃疡、肢端动脉痉挛症、手足发绀、老年性四肢冷感、中央视网膜炎、眼底出血等。也用于冠心病、心绞痛、视网膜血流障碍。
用量用法:
1.注射:临用时溶解(每1.5ml10单位)后进行肌注或皮注1次量10~20单位,每日1~2次。轻症每日10单位,以3周为1疗程。眼科亦可作眼结膜下注射,每次5单位。 2.口服:每次1片(含10单位),空腹时服。
注意事项:
1.凡肿瘤、颅内压增高、心力衰竭病人忌用。 2.有些病人应用后可出现疼痛反应。 3.本品对热、酸、碱、氧化剂均不稳定。
规格: 注射用血管舒缓素:每支10单位。片剂:每片10单位。



类别:周围血管扩张药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条